Quantum Data Centers in the Presence of Noise

Autor: Campbell, K., Lawey, A., Razavi, M.

Quantum Data Centers (QDCs) could overcome the scalability challenges of modern quantum computers. Single-processor monolithic quantum computers are affected by increased cross talk and difficulty of implementing gates when the number of qubits is in

Externí odkaz: http://arxiv.org/abs/2407.10769

Advances in Quantum Cryptography

Autor: Pirandola, S., Andersen, U. L., Banchi, L., Berta, M., Bunandar, D., Colbeck, R., Englund, D., Gehring, T., Lupo, C., Ottaviani, C., Pereira, J., Razavi, M., Shaari, J. S., Tomamichel, M., Usenko, V. C., Vallone, G., Villoresi, P., Wallden, P.

Publikováno v: Adv. Opt. Photon. 12, 1012-1236 (2020)

Quantum cryptography is arguably the fastest growing area in quantum information science. Novel theoretical protocols are designed on a regular basis, security proofs are constantly improving, and experiments are gradually moving from proof-of-princi

Externí odkaz: http://arxiv.org/abs/1906.01645

A high throughput immuno-affinity mass spectrometry method for detection and quantitation of SARS-CoV-2 nucleoprotein in human saliva and its comparison with RT-PCR, RT-LAMP, and lateral flow rapid antigen test.

Autor: Lane D; The Department of Chemical Pathology and Metabolic Diseases, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., Allsopp R; Department of Genetics and Genome Biology, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Holmes CW; Clinical Microbiology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK., Slingsby OC; van Geest MS-OMICS Facility, University of Leicester, Leicester, UK., Jukes-Jones R; The Department of Chemical Pathology and Metabolic Diseases, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK., Bird P; Clinical Microbiology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK., Anderson NL; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Razavi M; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Yip R; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Pearson TW; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Pope M; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Khunti K; Leicester Diabetes Centre, Leicester General Hospital, University of Leicester, Leicester, UK., Doykov I; Genetics & Genomic Medicine Department, Translational Mass Spectrometry Research Group, UCL Institute of Child Health, London, UK.; Great Ormond Street Biomedical Research Centre, UCL Institute of Child Health, London, UK., Hällqvist J; Genetics & Genomic Medicine Department, Translational Mass Spectrometry Research Group, UCL Institute of Child Health, London, UK.; Great Ormond Street Biomedical Research Centre, UCL Institute of Child Health, London, UK., Mills K; Genetics & Genomic Medicine Department, Translational Mass Spectrometry Research Group, UCL Institute of Child Health, London, UK.; Great Ormond Street Biomedical Research Centre, UCL Institute of Child Health, London, UK., Skipp P; Centre for Proteomic Research, University of Southampton, Southampton, UK., Carling R; Biochemical Sciences, Synnovis, Guys & St Thomas' NHSFT, London, UK.; GKT School Medical Education, Kings College London, London, UK., Ng L; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.; van Geest MS-OMICS Facility, University of Leicester, Leicester, UK., Shaw J; Department of Genetics and Genome Biology, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Gupta P; The Department of Chemical Pathology and Metabolic Diseases, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., Jones DJL; Department of Genetics and Genome Biology, Leicester Cancer Research Centre, University of Leicester, Leicester, UK.; van Geest MS-OMICS Facility, University of Leicester, Leicester, UK.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2024 Jan 23; Vol. 62 (6), pp. 1206-1216. Date of Electronic Publication: 2024 Jan 23 (Print Publication: 2024).

Magnesiothermic synthesis of HfB2–HfC-SiC nanocomposite by spark plasma technique

Autor: Shahriari, M., Zakeri, M., Razavi, M., Rahimipour, M.R.

Publikováno v: In Ceramics International 15 January 2021 47(2):2172-2179

The VIVID trial 12-month outcomes of the venous stent for the iliofemoral vein using the Duo venous stent system.

Autor: Razavi M; St. Joseph Heart and Vascular Center, Orange, CA. Electronic address: mrazavi@pacbell.net., Lichtenberg M; Vascular Center Arnsberg, Arnsberg., Desai K; Northwestern University, Chicago, IL., Dexter D; Sentara Vascular Specialists, Norfolk, VA., Soukas P; Lifespan Cardiovascular Institute, The Miriam Hospital, Providence, RI., Shammas N; Midwest Cardiovascular Research Foundation, Davenport, IA., Lodha A; Cardiovascular Institute of the South - Lafayette, Lafayette, LA., Gagne P; Vascular Care Connecticut, Darien, CT., Nordell A; Technomics Research, Long Lake, MN., Kolluri R; Ohio Health Heart and Vascular, Columbus, OH., Garcia M; Endovascular Consultants, Wilmington, NC.

Publikováno v: Journal of vascular surgery. Venous and lymphatic disorders [J Vasc Surg Venous Lymphat Disord] 2024 Oct 29, pp. 101995. Date of Electronic Publication: 2024 Oct 29.